Executive Education Program

Executive Education programTexas A&M University School of Law (TAMU Law) ​and the Confederation of Indian Industries (CII)​ present

"Health, Pharmaceuticals & Intellectual Property Rights"

Texas A&M University School of Law in partnership with the Confederation of Indian Industry Online Learning Academy ​presents an Executive Education Program on Health, Pharmaceuticals and Intellectual Property Rights. Over four weekends in September, the online program will bring together academic and industry leaders to discuss issues around patent law and policy, pharmaceuticals policy, regulatory issues, the use of technology, the global trade regime, and other barriers to health care and medication. This will be an opportunity for industry leaders to explore various promising opportunities in an academic setting, and to look beyond​ COVID-19 to the future course of health care, access, and innovation in developing country pharmaceutical industries. Join us for a special open session on September 27th.

Executive Education Open Session Sept 27


Sunday, September 27, 2020 7:30 am, Central Daylight Time (Chicago, GMT-05:00)
Sunday, September 27, 2020 6:00 pm, India Time (Mumbai, GMT+05:30)

September 5​-6, 12​-13, 19​-20, 26​-27, 2020
8-day program  |  3 hours/day, 7:30-10:30 am Central (US), 1800-2100 (India)  |  Weekends in September


Fees Structure:  $200 (USD) plus 18% GST;  Rs. 15,000/- plus 18% GST 


  • Renowned global Faculty
  • ​Weekend courses of only 3 hours per day
  • Joint certification by CII and Texas A&M University School of Law
  • 100% online - earn your certificate from ​the safety and comfort of your home

Who can participate?

The course will be useful to
  • patent professionals
  • R&D and innovation managers
  • technology analysts
  • IP decision makers from industry, academic and R&D institutions


  • IP Strategy Fundamentals
  • Regulatory Exclusivity
  • Recent Trends and Issues at USPTO
  • Global Alliances & COVID-19
  • Patents & Trade Issues
  • COVID-19 & Changes to Global Health
  • Tech Transfer; Pharmaceutical Protection & Access Issues in India
  • FDA & Related Issues
  • Public-Private Partnerships
  • Advocacy Strategies from Innovation and Generic Perspective
  • USTR & its Role
  • Oppositions and Injunctions: Indian Patent Jurisprudence​
  • Bayh-Dole Act and its Role in the US Comparison with India
  • Access vs Innovation (AAM collaboration and foreign generics)


Srividhya Ragavan
Professor of Law
Texas A&M University School of Law; Fort Worth, Texas, U.S.A.

Doris Estelle Long
Professor Emeritus of Law and Former Director of the Center for Intellectual Property, Information and Privacy Law 
UIC John Marshall Law School; Chicago, Illinois, U.S.A.

Peter K. Yu
Professor of Law, Director of the Center for Law & Intellectual Property
Texas A&M University School of Law; Fort Worth, Texas, U.S.A.
Professor of Communication 
Texas A&M University; College Station, Texas, U.S.A. 

Swaraj Paul Barooah
Independent Consultant, IP Law and Policy
Managing Editor, SpicyIP.com

Shawn Brown
Vice President of Government Affairs
Lupin Pharmaceuticals, Mumbai, Maharashtra, India

Jonathan Kimball
Vice President of Trade and International Affairs
Association for Accessible Medicines (AAM); Washington, D.C., U.S.A.

Michael Mireles
Professor of Law, Director, Intellectual Property Certificate of Concentration
University of the Pacific McGeorge School of Law; Sacramento, California, U.S.A.

Guru Nataraj
Law Chambers of G. Nataraj; Noida, Uttar Pradesh, India

Murali Neelakantan
amicus; Mumbai, Maharashtra, India

Michael Palmedo
Assistant Director PIJIP
American University Washington College of Law; Washington D.C., U.S.A.

Sandeep K. Rathod
General Counsel and Vice President (Legal)
USV Private Limited; Mumbai, Maharashtra, India

Ana Santos Rutschman
Assistant Professor of Law
Center for Health Law Studies, Center for International & Comparative Law, Saint Louis University School of Law; St. Louis, Missouri, U.S.A.

Rajkumar Vinnakota
Janik Vinnakota LLP; Dallas, Texas, U.S.A.

Program ​Organizers

Texas A&M University School of Law

THUMB_ORIENTATION_NOTEBOOK_LOGOTexas A&M University School of Law is emerging as a national and international leader in the realm of health law and policy. The new Health Law, Policy & Management concentration of its master’s degree program for non-lawyers is growing in leaps and bounds. Its nationally ranked program in intellectual property – the Center for Law & Intellectual Property (CLIP) – is likewise actively engaged in issues related to access to medications, pharmaceutical innovation, and the role of big data and artificial intelligence in health. The Law School is also collaborating closely with other institutions on new initiatives and programs, including the Texas A&M School of Public Health, Tarrant County College’s nursing program, and the new medical school established by TCU and UNT Health Science Centers – for which the Law School is helping to develop curriculum on health law and policy.

Most recently, Professor Srividhya Ragavan, a leading scholar working at the intersection of access to medications, intellectual property, and international trade, has collaborated with the Association for Affordable Medicines to establish a new blog – TradeRxReport.com – which aims to collect timely and impactful information and insights on trade and pharmaceuticals.

With its strength in international law and distinctly ​international faculty, Texas A&M University School of Law is a truly global law school. In particular, given close faculty connections to India, the Law School is focused on developing new collaborations and initiatives with the Indian legal and business communities. Earlier this year, Dean Robert B. Ahdieh and Professor Ragavan spent nearly two weeks visiting universities (including not only law schools, but business and science programs as well), lawyers, judges, and various companies across ​India, to identify opportunities for collaboration. Out of those conversations there have already emerged various new degree programs, other non-degree academic partnerships, judicial collaborations, and industry-related initiatives. Given the Law School’s strengths in international law, health law and policy, intellectual property, and trade law – as well as the large and strong expatriate Indian community in Texas, including a growing number of headquarters of India companies – such Texas A&M School of Law partnerships with India are expected to grow rapidly in the years ahead.

Confederation of Indian Industry (CII) 

CII logoThe Confederation of Indian Industry (CII) works to create and sustain an environment conducive to the development of India, partnering Industry, Government, and civil society through working closely with Government on policy issues, interfacing with thought leaders, and enhancing efficiency, competitiveness and business opportunities for industry. 

For 125 years, CII has been working on shaping India's development journey and, this year, more than ever before, it will continue to proactively transform Indian industry's engagement in national development. The premier business association has more than 9100 members, from the private as well as public sectors, and an indirect membership of over 300,000 enterprises from around 288 national and regional sectoral industry bodies. 

With 68 offices, including 9 Centres of Excellence in India, and 1 0 overseas offices in Australia, China, Egypt, France, Germany, Indonesia, Singapore, UAE, UK, and USA, as well as institutional partnerships with 394 counterpart organizations in 133 countries, CII serves as a reference point for Indian industry and the international business community.